{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,19]],"date-time":"2025-11-19T11:35:28Z","timestamp":1763552128671},"reference-count":14,"publisher":"Georg Thieme Verlag KG","issue":"05","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["An\u00e4sthesiol Intensivmed Notfallmed Schmerzther"],"published-print":{"date-parts":[[2021,5]]},"abstract":"<jats:title>Zusammenfassung<\/jats:title><jats:p>Die maligne Hyperthermie ist eine seltene, in der Regel subklinische metabolische Myopathie, die zu einer lebensbedrohlichen metabolischen Entgleisung f\u00fchren kann. Um im Falle einer notwendigen An\u00e4sthesie eine Gef\u00e4hrdung der Betroffenen zu vermeiden, m\u00fcssen im Vorfeld entsprechende Vorkehrungen getroffen werden. Gerade bei einer Schwangerschaft stellt dies den An\u00e4sthesisten vor erheblichen Herausforderungen.<\/jats:p><jats:p>Durch die Europ\u00e4ische Maligne Hyperthermie Gruppe wurde im Mai 2019 eine Richtlinie zum Vorgehen bei einer gesicherten oder vermuteten Disposition zur malignen Hyperthermie und einer Schwangerschaft publiziert. Der vorliegende Artikel fasst die Empfehlungen zusammen und beschreibt m\u00f6gliche Vorgehensweisen bei der Betreuung von schwangeren Patientinnen mit einer MH-Veranlagung.<\/jats:p>","DOI":"10.1055\/a-1260-8975","type":"journal-article","created":{"date-parts":[[2021,5,26]],"date-time":"2021-05-26T22:31:28Z","timestamp":1622068288000},"page":"367-372","source":"Crossref","is-referenced-by-count":2,"title":["Maligne Hyperthermie und Schwangerschaft \u2013 Empfehlungen der Europ\u00e4ischen Malignen Hyperthermie Gruppe"],"prefix":"10.1055","volume":"56","author":[{"given":"Frank","family":"Schuster","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephan","family":"Johannsen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"194","published-online":{"date-parts":[[2021,5,26]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1007\/s00101-014-2351-6","article-title":"Homozygous and compound heterozygous RYR1 mutations. New findings on prevalence and penetrance of malignant hyperthermia","volume":"8\u200a\u2013\u200a9","author":"S Wolak","year":"2014","journal-title":"Anaesthesist"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1007\/s00540-006-0467-9","article-title":"Epidural anesthetic management using ropivacaine in a parturient with multi-minicore disease and susceptibility to malignant hyperthermia","volume":"21","author":"O Saito","year":"2007","journal-title":"J Anesth"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1159\/000077658","article-title":"Multi-minicore disease with susceptibility to malignant hyperthermia in pregnancy","volume":"58","author":"H Osada","year":"2004","journal-title":"Gynecol Obstet Invest"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1213\/ANE.0000000000000208","article-title":"The sevoflurane washout profile of seven recent anesthesia workstations for malignant hyperthermia-susceptible adults and infants: a bench test study","volume":"119","author":"N Cottron","year":"2014","journal-title":"Anesth Analg"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1055\/s-0032-1330932","article-title":"Medikament in der Schwangerschaft \u2013 Welche Substanzen eignen sich im Akutfall?","volume":"2","author":"D Nauheimer","year":"2012","journal-title":"Lege artis"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1213\/ANE.0b013e3181c6b9b2","article-title":"Clinical presentation, treatment, and complications of malignant hyperthermia in North America from 1987 to 2006","volume":"110","author":"M G Larach","year":"2010","journal-title":"Anesth Analg"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/1750-1172-9-8","article-title":"Functional and genetic characterization of clinical malignant hyperthermia crises: a multicenter study","volume":"9","author":"W Klingler","year":"2014","journal-title":"Orphanet J Rare Dis"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1097\/00000542-199406000-00009","article-title":"Masseter muscle rigidity and malignant hyperthermia susceptibility in pediatric patients. An update on management and diagnosis","volume":"80","author":"R P O\u02bcFlynn","year":"1994","journal-title":"Anesthesiology"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/1471-2253-14-14","article-title":"The effect of succinylcholine on malignant hyperthermia events in susceptible swine","volume":"14","author":"F Schuster","year":"2014","journal-title":"BMC Anesthesiol"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1093\/bja\/aer132","article-title":"Malignant hyperthermia: pharmacology of triggering","volume":"107","author":"P M Hopkins","year":"2011","journal-title":"Br J Anaesth"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1055\/a-0725-7577","article-title":"Pharmakologische Therapie der Malignen Hyperthermie. Update 2019","volume":"54","author":"F Schuster","year":"2019","journal-title":"Anasthesiol Intensivmed Notfallmed Schmerzther"},{"key":"ref16","first-page":"204","article-title":"S1-Leitlinie: Therapie der malignen Hyperthermie","volume":"59","author":"W Klingler","year":"2018","journal-title":"An\u00e4sth Intensivmed"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.bja.2020.04.089","article-title":"Availability of dantrolene for the management of malignant hyperthermia crises: European Malignant Hyperthermia Group guidelines","volume":"125","author":"K PE Glahn","year":"2020","journal-title":"Br J Anaesth"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/1471-2253-13-24","article-title":"Evaluation of suspected malignant hyperthermia events during anesthesia","volume":"13","author":"F Schuster","year":"2013","journal-title":"BMC Anesthesiol"}],"container-title":["AINS - An\u00e4sthesiologie \u00b7 Intensivmedizin \u00b7 Notfallmedizin \u00b7 Schmerztherapie"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/www.thieme-connect.de\/products\/ejournals\/pdf\/10.1055\/a-1260-8975.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,26]],"date-time":"2021-05-26T22:34:04Z","timestamp":1622068444000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.thieme-connect.de\/DOI\/DOI?10.1055\/a-1260-8975"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5]]},"references-count":14,"journal-issue":{"issue":"05","published-online":{"date-parts":[[2021,5,26]]},"published-print":{"date-parts":[[2021,5]]}},"URL":"https:\/\/doi.org\/10.1055\/a-1260-8975","relation":{},"ISSN":["0939-2661","1439-1074"],"issn-type":[{"value":"0939-2661","type":"print"},{"value":"1439-1074","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,5]]}}}